This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
First quarter 2010 results date notification
Boehringer Ingelheim grows faster than the pharmaceutical market
Firm ready to release heart drug
Tamoxifen “halves cancer risk”
Approval for Lannett nausea drug
Evolva Holding SA announces financial results for 2009
Bayer HealthCare marks 2010 World Hemophilia Day
Pharmacists put patient care under the microscope
Lung cancer drugs trial revealed
FDA may drop GSK drug safety study
Targeted cancer drug tests issued
Prostate cancer trial breakthrough
« Previous
1
…
73
74
75
76
77
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: